Table 3.
State (As of)/ Age Group |
Proportion (%) |
Particpants Per 1000a |
State (As of)/ Age Group |
Proportion (%) |
Participants Per 1000a |
State (As of)/ Age Group |
Proportion (%) |
Patients Per 1000a |
---|---|---|---|---|---|---|---|---|
Alaska (June 2015) | Montana (May 2015) | Rhode Island (June 2015) | ||||||
Under 18 | <1.0 | <0.1 | Under 18 | <1.0 | <0.1 | 21 & Under | 2.2 | 0.9 |
18–24 | 4.1 | 0.9 | 18–20 | 1.9 | 5.4 | 22–29 | 13.0 | 12.9 |
25–29 | 6.2 | 1.7 | 21–30 | 15.6 | 13.8 | 30–39 | 20.8 | 19.3 |
30–39 | 17.6 | 2.9 | 31–40 | 20.1 | 19.9 | 40–49 | 19.9 | 16.1 |
40–49 | 18.2 | 3.3 | 41–50 | 17.0 | 16.5 | 50–59 | 24.1 | 17.6 |
50–59 | 28.5 | 4.4 | 51–60 | 25.9 | 19.7 | 60–69 | 16.4 | 16.4 |
60–69 | 19.4 | 4.3 | 61–70 | 16.6 | 16.1 | 70 & Over | 3.6 | 3.7 |
70 & Over | 3.0 | 1.2 | 71 & Over | 2.9 | 3.4 | |||
Arizona (April 2015) | Nevada (Jan. 2014) | Vermont (Jan. 2015) | ||||||
Under 18 | <1.0 | <0.1 | Under 18 | <1.0 | <0.1 | Under 18 | <1.0 | <1.0 |
18–30 | 23.9 | 14.0 | 18–20 | <1.0 | 0.5 | 18–24 | 1.4 | <1.0 |
31–40 | 20.0 | 16.5 | 21–24 | 3.8 | 1.2 | 25–34 | 8.6 | 2.0 |
41–50 | 15.9 | 13.4 | 25–34 | 18.9 | 2.4 | 35–44 | 16.4 | 3.7 |
51–60 | 20.1 | 16.8 | 35–44 | 18.9 | 2.4 | 45–54 | 25.2 | 4.5 |
61–70 | 15.9 | 15.7 | 45–54 | 21.2 | 2.7 | 55–64 | 31.3 | 5.3 |
71 & Over | 4.1 | 4.3 | 55–64 | 23.1 | 3.3 | 65 & Over | 16.5 | 2.5 |
65 & Over | 13.0 | 1.7 | ||||||
Colorado (April 2015) | Oregon (April 2015) | |||||||
Under 18 | <1.0 | <1.0 | Under 18 | <1.0 | <1.0 | |||
18–20 | 5.0 | 28.7 | 18–20 | 1.3 | 6.5 | |||
21–30 | 23.0 | 34.9 | 21–24 | 4.3 | 14.0 | |||
31–40 | 20.7 | 32.9 | 25–29 | 8.1 | 22.0 | |||
41–50 | 16.1 | 26.1 | 30–39 | 20.7 | 28.0 | |||
51–60 | 19.0 | 30.4 | 40–49 | 17.2 | 24.4 | |||
61–70 | 13.2 | 30.0 | 50–59 | 23.3 | 30.5 | |||
71 & Over | 2.4 | 7.4 | 60–69 | 20.3 | 30.9 | |||
70 & Over | 5.1 | 9.0 |
Denominator of prevalence proportion used age-specific state population based on US Census estimates for 2014.